Company intelligence / Profile preview

Canexis Pharma

Schlattingen / Basadingen-Schlattingen, Thurgau, Switzerlandcanexis.ch ↗
Ownership
Private
Development stage
Other
01

Overview

Canexis Pharma AG is a Swiss GMP-certified manufacturer specializing in high-purity medical cannabis extracts and active pharmaceutical ingredients, including cannabidiol and dronabinol. The company has received Swissmedic approval for large-scale production, positioning itself as a key supplier for both bespoke prescription medicines and future finished pharmaceuticals. Its facility can process up to 1,000 kg of cannabis per day, producing up to 100 kg of pure product daily. The company emphasizes quality, regulatory compliance, and long-term commitment to the evolving cannabinoid-based pharmaceuticals market

Therapeutic areas
NeurologyOther
Modalities
Small molecule (for cannabinoids such as cannabidiol and dronabinol)Plant extract
Industry
Contract Manufacturing Organization
02

Partnerships

No major pharma/biotech partnerships publicly disclosed; knowledge-sharing with leading U.S. cannabis firms mentioned

Beyond the preview

Go deeper on Canexis Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Canexis Pharma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call